nodes	percent_of_prediction	percent_of_DWPC	metapath
Valganciclovir—Depression—Capecitabine—colon cancer	0.00159	0.00159	CcSEcCtD
Valganciclovir—Renal failure—Capecitabine—colon cancer	0.00157	0.00157	CcSEcCtD
Valganciclovir—Discomfort—Irinotecan—colon cancer	0.00156	0.00156	CcSEcCtD
Valganciclovir—Neuropathy peripheral—Capecitabine—colon cancer	0.00156	0.00156	CcSEcCtD
Valganciclovir—Anaphylactic shock—Vincristine—colon cancer	0.00156	0.00156	CcSEcCtD
Valganciclovir—Oedema—Vincristine—colon cancer	0.00156	0.00156	CcSEcCtD
Valganciclovir—Stomatitis—Capecitabine—colon cancer	0.00155	0.00155	CcSEcCtD
Valganciclovir—Jaundice—Capecitabine—colon cancer	0.00155	0.00155	CcSEcCtD
Valganciclovir—Infection—Vincristine—colon cancer	0.00155	0.00155	CcSEcCtD
Valganciclovir—Urinary tract infection—Capecitabine—colon cancer	0.00155	0.00155	CcSEcCtD
Valganciclovir—Convulsion—Fluorouracil—colon cancer	0.00154	0.00154	CcSEcCtD
Valganciclovir—Confusional state—Irinotecan—colon cancer	0.00153	0.00153	CcSEcCtD
Valganciclovir—Nervous system disorder—Vincristine—colon cancer	0.00153	0.00153	CcSEcCtD
Valganciclovir—Thrombocytopenia—Vincristine—colon cancer	0.00153	0.00153	CcSEcCtD
Valganciclovir—Haematuria—Capecitabine—colon cancer	0.00152	0.00152	CcSEcCtD
Valganciclovir—Anaphylactic shock—Irinotecan—colon cancer	0.00152	0.00152	CcSEcCtD
Valganciclovir—Oedema—Irinotecan—colon cancer	0.00152	0.00152	CcSEcCtD
Valganciclovir—Infection—Irinotecan—colon cancer	0.00151	0.00151	CcSEcCtD
Valganciclovir—Hyperhidrosis—Vincristine—colon cancer	0.00151	0.00151	CcSEcCtD
Valganciclovir—Hepatobiliary disease—Capecitabine—colon cancer	0.00151	0.00151	CcSEcCtD
Valganciclovir—Discomfort—Fluorouracil—colon cancer	0.0015	0.0015	CcSEcCtD
Valganciclovir—Nervous system disorder—Irinotecan—colon cancer	0.00149	0.00149	CcSEcCtD
Valganciclovir—Thrombocytopenia—Irinotecan—colon cancer	0.00149	0.00149	CcSEcCtD
Valganciclovir—Anorexia—Vincristine—colon cancer	0.00149	0.00149	CcSEcCtD
Valganciclovir—Hyperhidrosis—Irinotecan—colon cancer	0.00147	0.00147	CcSEcCtD
Valganciclovir—Confusional state—Fluorouracil—colon cancer	0.00147	0.00147	CcSEcCtD
Valganciclovir—Hypotension—Vincristine—colon cancer	0.00146	0.00146	CcSEcCtD
Valganciclovir—Anaphylactic shock—Fluorouracil—colon cancer	0.00145	0.00145	CcSEcCtD
Valganciclovir—Oedema—Fluorouracil—colon cancer	0.00145	0.00145	CcSEcCtD
Valganciclovir—Anorexia—Irinotecan—colon cancer	0.00145	0.00145	CcSEcCtD
Valganciclovir—Ataxia—Methotrexate—colon cancer	0.00145	0.00145	CcSEcCtD
Valganciclovir—Infection—Fluorouracil—colon cancer	0.00144	0.00144	CcSEcCtD
Valganciclovir—Haemoglobin—Capecitabine—colon cancer	0.00144	0.00144	CcSEcCtD
Valganciclovir—Haemorrhage—Capecitabine—colon cancer	0.00143	0.00143	CcSEcCtD
Valganciclovir—Hepatitis—Capecitabine—colon cancer	0.00143	0.00143	CcSEcCtD
Valganciclovir—Nervous system disorder—Fluorouracil—colon cancer	0.00143	0.00143	CcSEcCtD
Valganciclovir—Thrombocytopenia—Fluorouracil—colon cancer	0.00142	0.00142	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Vincristine—colon cancer	0.00142	0.00142	CcSEcCtD
Valganciclovir—Pharyngitis—Capecitabine—colon cancer	0.00142	0.00142	CcSEcCtD
Valganciclovir—Tachycardia—Fluorouracil—colon cancer	0.00142	0.00142	CcSEcCtD
Valganciclovir—Hypotension—Irinotecan—colon cancer	0.00142	0.00142	CcSEcCtD
Valganciclovir—Urinary tract disorder—Capecitabine—colon cancer	0.00141	0.00141	CcSEcCtD
Valganciclovir—Insomnia—Vincristine—colon cancer	0.00141	0.00141	CcSEcCtD
Valganciclovir—Oedema peripheral—Capecitabine—colon cancer	0.00141	0.00141	CcSEcCtD
Valganciclovir—Connective tissue disorder—Capecitabine—colon cancer	0.00141	0.00141	CcSEcCtD
Valganciclovir—Urethral disorder—Capecitabine—colon cancer	0.0014	0.0014	CcSEcCtD
Valganciclovir—Paraesthesia—Vincristine—colon cancer	0.0014	0.0014	CcSEcCtD
Valganciclovir—Anorexia—Fluorouracil—colon cancer	0.00139	0.00139	CcSEcCtD
Valganciclovir—Visual impairment—Capecitabine—colon cancer	0.00138	0.00138	CcSEcCtD
Valganciclovir—Insomnia—Irinotecan—colon cancer	0.00137	0.00137	CcSEcCtD
Valganciclovir—Paraesthesia—Irinotecan—colon cancer	0.00136	0.00136	CcSEcCtD
Valganciclovir—Hypotension—Fluorouracil—colon cancer	0.00136	0.00136	CcSEcCtD
Valganciclovir—Decreased appetite—Vincristine—colon cancer	0.00135	0.00135	CcSEcCtD
Valganciclovir—Dyspnoea—Irinotecan—colon cancer	0.00135	0.00135	CcSEcCtD
Valganciclovir—Somnolence—Irinotecan—colon cancer	0.00135	0.00135	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Vincristine—colon cancer	0.00135	0.00135	CcSEcCtD
Valganciclovir—Fatigue—Vincristine—colon cancer	0.00134	0.00134	CcSEcCtD
Valganciclovir—Eye disorder—Capecitabine—colon cancer	0.00134	0.00134	CcSEcCtD
Valganciclovir—Dyspepsia—Irinotecan—colon cancer	0.00134	0.00134	CcSEcCtD
Valganciclovir—Tinnitus—Capecitabine—colon cancer	0.00133	0.00133	CcSEcCtD
Valganciclovir—Pain—Vincristine—colon cancer	0.00133	0.00133	CcSEcCtD
Valganciclovir—Constipation—Vincristine—colon cancer	0.00133	0.00133	CcSEcCtD
Valganciclovir—Cardiac disorder—Capecitabine—colon cancer	0.00133	0.00133	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00132	0.00132	CcSEcCtD
Valganciclovir—Decreased appetite—Irinotecan—colon cancer	0.00132	0.00132	CcSEcCtD
Valganciclovir—Eosinophilia—Methotrexate—colon cancer	0.00132	0.00132	CcSEcCtD
Valganciclovir—Insomnia—Fluorouracil—colon cancer	0.00131	0.00131	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Irinotecan—colon cancer	0.00131	0.00131	CcSEcCtD
Valganciclovir—Fatigue—Irinotecan—colon cancer	0.00131	0.00131	CcSEcCtD
Valganciclovir—Paraesthesia—Fluorouracil—colon cancer	0.00131	0.00131	CcSEcCtD
Valganciclovir—Pancreatitis—Methotrexate—colon cancer	0.0013	0.0013	CcSEcCtD
Valganciclovir—Pain—Irinotecan—colon cancer	0.0013	0.0013	CcSEcCtD
Valganciclovir—Constipation—Irinotecan—colon cancer	0.0013	0.0013	CcSEcCtD
Valganciclovir—Angiopathy—Capecitabine—colon cancer	0.0013	0.0013	CcSEcCtD
Valganciclovir—Dyspnoea—Fluorouracil—colon cancer	0.0013	0.0013	CcSEcCtD
Valganciclovir—Somnolence—Fluorouracil—colon cancer	0.00129	0.00129	CcSEcCtD
Valganciclovir—Immune system disorder—Capecitabine—colon cancer	0.00129	0.00129	CcSEcCtD
Valganciclovir—Mediastinal disorder—Capecitabine—colon cancer	0.00129	0.00129	CcSEcCtD
Valganciclovir—Chills—Capecitabine—colon cancer	0.00128	0.00128	CcSEcCtD
Valganciclovir—Dyspepsia—Fluorouracil—colon cancer	0.00128	0.00128	CcSEcCtD
Valganciclovir—Arrhythmia—Capecitabine—colon cancer	0.00128	0.00128	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Vincristine—colon cancer	0.00127	0.00127	CcSEcCtD
Valganciclovir—Decreased appetite—Fluorouracil—colon cancer	0.00126	0.00126	CcSEcCtD
Valganciclovir—Alopecia—Capecitabine—colon cancer	0.00126	0.00126	CcSEcCtD
Valganciclovir—Pancytopenia—Methotrexate—colon cancer	0.00126	0.00126	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00126	0.00126	CcSEcCtD
Valganciclovir—Mental disorder—Capecitabine—colon cancer	0.00125	0.00125	CcSEcCtD
Valganciclovir—Feeling abnormal—Irinotecan—colon cancer	0.00125	0.00125	CcSEcCtD
Valganciclovir—Malnutrition—Capecitabine—colon cancer	0.00124	0.00124	CcSEcCtD
Valganciclovir—Neutropenia—Methotrexate—colon cancer	0.00124	0.00124	CcSEcCtD
Valganciclovir—Dysuria—Methotrexate—colon cancer	0.00124	0.00124	CcSEcCtD
Valganciclovir—Pain—Fluorouracil—colon cancer	0.00124	0.00124	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Irinotecan—colon cancer	0.00124	0.00124	CcSEcCtD
Valganciclovir—Upper respiratory tract infection—Methotrexate—colon cancer	0.00124	0.00124	CcSEcCtD
Valganciclovir—Abdominal pain—Vincristine—colon cancer	0.00123	0.00123	CcSEcCtD
Valganciclovir—Body temperature increased—Vincristine—colon cancer	0.00123	0.00123	CcSEcCtD
Valganciclovir—Flatulence—Capecitabine—colon cancer	0.00123	0.00123	CcSEcCtD
Valganciclovir—Erectile dysfunction—Methotrexate—colon cancer	0.00122	0.00122	CcSEcCtD
Valganciclovir—Dysgeusia—Capecitabine—colon cancer	0.00122	0.00122	CcSEcCtD
Valganciclovir—Photosensitivity reaction—Methotrexate—colon cancer	0.00121	0.00121	CcSEcCtD
Valganciclovir—Back pain—Capecitabine—colon cancer	0.0012	0.0012	CcSEcCtD
Valganciclovir—Abdominal pain—Irinotecan—colon cancer	0.0012	0.0012	CcSEcCtD
Valganciclovir—Body temperature increased—Irinotecan—colon cancer	0.0012	0.0012	CcSEcCtD
Valganciclovir—Feeling abnormal—Fluorouracil—colon cancer	0.0012	0.0012	CcSEcCtD
Valganciclovir—Muscle spasms—Capecitabine—colon cancer	0.0012	0.0012	CcSEcCtD
Valganciclovir—Pneumonia—Methotrexate—colon cancer	0.00119	0.00119	CcSEcCtD
Valganciclovir—Infestation—Methotrexate—colon cancer	0.00119	0.00119	CcSEcCtD
Valganciclovir—Infestation NOS—Methotrexate—colon cancer	0.00119	0.00119	CcSEcCtD
Valganciclovir—Depression—Methotrexate—colon cancer	0.00118	0.00118	CcSEcCtD
Valganciclovir—Vision blurred—Capecitabine—colon cancer	0.00117	0.00117	CcSEcCtD
Valganciclovir—Tremor—Capecitabine—colon cancer	0.00117	0.00117	CcSEcCtD
Valganciclovir—Renal failure—Methotrexate—colon cancer	0.00117	0.00117	CcSEcCtD
Valganciclovir—Stomatitis—Methotrexate—colon cancer	0.00116	0.00116	CcSEcCtD
Valganciclovir—Ill-defined disorder—Capecitabine—colon cancer	0.00115	0.00115	CcSEcCtD
Valganciclovir—Urticaria—Fluorouracil—colon cancer	0.00115	0.00115	CcSEcCtD
Valganciclovir—Anaemia—Capecitabine—colon cancer	0.00115	0.00115	CcSEcCtD
Valganciclovir—Body temperature increased—Fluorouracil—colon cancer	0.00115	0.00115	CcSEcCtD
Valganciclovir—Hypersensitivity—Vincristine—colon cancer	0.00115	0.00115	CcSEcCtD
Valganciclovir—Haematuria—Methotrexate—colon cancer	0.00113	0.00113	CcSEcCtD
Valganciclovir—Malaise—Capecitabine—colon cancer	0.00112	0.00112	CcSEcCtD
Valganciclovir—Hepatobiliary disease—Methotrexate—colon cancer	0.00112	0.00112	CcSEcCtD
Valganciclovir—Vertigo—Capecitabine—colon cancer	0.00112	0.00112	CcSEcCtD
Valganciclovir—Hypersensitivity—Irinotecan—colon cancer	0.00112	0.00112	CcSEcCtD
Valganciclovir—Asthenia—Vincristine—colon cancer	0.00112	0.00112	CcSEcCtD
Valganciclovir—Leukopenia—Capecitabine—colon cancer	0.00111	0.00111	CcSEcCtD
Valganciclovir—Asthenia—Irinotecan—colon cancer	0.00109	0.00109	CcSEcCtD
Valganciclovir—Cough—Capecitabine—colon cancer	0.00109	0.00109	CcSEcCtD
Valganciclovir—Hypertension—Capecitabine—colon cancer	0.00107	0.00107	CcSEcCtD
Valganciclovir—Hypersensitivity—Fluorouracil—colon cancer	0.00107	0.00107	CcSEcCtD
Valganciclovir—Haemoglobin—Methotrexate—colon cancer	0.00107	0.00107	CcSEcCtD
Valganciclovir—Diarrhoea—Vincristine—colon cancer	0.00107	0.00107	CcSEcCtD
Valganciclovir—Haemorrhage—Methotrexate—colon cancer	0.00106	0.00106	CcSEcCtD
Valganciclovir—Hepatitis—Methotrexate—colon cancer	0.00106	0.00106	CcSEcCtD
Valganciclovir—Arthralgia—Capecitabine—colon cancer	0.00106	0.00106	CcSEcCtD
Valganciclovir—Pharyngitis—Methotrexate—colon cancer	0.00106	0.00106	CcSEcCtD
Valganciclovir—Anxiety—Capecitabine—colon cancer	0.00106	0.00106	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00105	0.00105	CcSEcCtD
Valganciclovir—Urinary tract disorder—Methotrexate—colon cancer	0.00105	0.00105	CcSEcCtD
Valganciclovir—Discomfort—Capecitabine—colon cancer	0.00105	0.00105	CcSEcCtD
Valganciclovir—Urethral disorder—Methotrexate—colon cancer	0.00104	0.00104	CcSEcCtD
Valganciclovir—Diarrhoea—Irinotecan—colon cancer	0.00104	0.00104	CcSEcCtD
Valganciclovir—Dry mouth—Capecitabine—colon cancer	0.00104	0.00104	CcSEcCtD
Valganciclovir—Dizziness—Vincristine—colon cancer	0.00103	0.00103	CcSEcCtD
Valganciclovir—Pruritus—Fluorouracil—colon cancer	0.00103	0.00103	CcSEcCtD
Valganciclovir—Visual impairment—Methotrexate—colon cancer	0.00103	0.00103	CcSEcCtD
Valganciclovir—Confusional state—Capecitabine—colon cancer	0.00102	0.00102	CcSEcCtD
Valganciclovir—Oedema—Capecitabine—colon cancer	0.00102	0.00102	CcSEcCtD
Valganciclovir—Infection—Capecitabine—colon cancer	0.00101	0.00101	CcSEcCtD
Valganciclovir—Dizziness—Irinotecan—colon cancer	0.001	0.001	CcSEcCtD
Valganciclovir—Nervous system disorder—Capecitabine—colon cancer	0.000996	0.000996	CcSEcCtD
Valganciclovir—Eye disorder—Methotrexate—colon cancer	0.000995	0.000995	CcSEcCtD
Valganciclovir—Diarrhoea—Fluorouracil—colon cancer	0.000995	0.000995	CcSEcCtD
Valganciclovir—Thrombocytopenia—Capecitabine—colon cancer	0.000995	0.000995	CcSEcCtD
Valganciclovir—Tinnitus—Methotrexate—colon cancer	0.000992	0.000992	CcSEcCtD
Valganciclovir—Tachycardia—Capecitabine—colon cancer	0.000991	0.000991	CcSEcCtD
Valganciclovir—Vomiting—Vincristine—colon cancer	0.000991	0.000991	CcSEcCtD
Valganciclovir—Cardiac disorder—Methotrexate—colon cancer	0.000988	0.000988	CcSEcCtD
Valganciclovir—Skin disorder—Capecitabine—colon cancer	0.000987	0.000987	CcSEcCtD
Valganciclovir—Hyperhidrosis—Capecitabine—colon cancer	0.000982	0.000982	CcSEcCtD
Valganciclovir—Dermatitis—Vincristine—colon cancer	0.000982	0.000982	CcSEcCtD
Valganciclovir—Headache—Vincristine—colon cancer	0.000976	0.000976	CcSEcCtD
Valganciclovir—Anorexia—Capecitabine—colon cancer	0.000968	0.000968	CcSEcCtD
Valganciclovir—Angiopathy—Methotrexate—colon cancer	0.000966	0.000966	CcSEcCtD
Valganciclovir—Vomiting—Irinotecan—colon cancer	0.000965	0.000965	CcSEcCtD
Valganciclovir—Immune system disorder—Methotrexate—colon cancer	0.000961	0.000961	CcSEcCtD
Valganciclovir—Dizziness—Fluorouracil—colon cancer	0.000961	0.000961	CcSEcCtD
Valganciclovir—Mediastinal disorder—Methotrexate—colon cancer	0.000959	0.000959	CcSEcCtD
Valganciclovir—Dermatitis—Irinotecan—colon cancer	0.000956	0.000956	CcSEcCtD
Valganciclovir—Chills—Methotrexate—colon cancer	0.000955	0.000955	CcSEcCtD
Valganciclovir—Headache—Irinotecan—colon cancer	0.000951	0.000951	CcSEcCtD
Valganciclovir—Hypotension—Capecitabine—colon cancer	0.000949	0.000949	CcSEcCtD
Valganciclovir—Alopecia—Methotrexate—colon cancer	0.000941	0.000941	CcSEcCtD
Valganciclovir—Mental disorder—Methotrexate—colon cancer	0.000933	0.000933	CcSEcCtD
Valganciclovir—Malnutrition—Methotrexate—colon cancer	0.000927	0.000927	CcSEcCtD
Valganciclovir—Nausea—Vincristine—colon cancer	0.000926	0.000926	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000926	0.000926	CcSEcCtD
Valganciclovir—Vomiting—Fluorouracil—colon cancer	0.000924	0.000924	CcSEcCtD
Valganciclovir—Insomnia—Capecitabine—colon cancer	0.000919	0.000919	CcSEcCtD
Valganciclovir—Dermatitis—Fluorouracil—colon cancer	0.000916	0.000916	CcSEcCtD
Valganciclovir—Paraesthesia—Capecitabine—colon cancer	0.000912	0.000912	CcSEcCtD
Valganciclovir—Headache—Fluorouracil—colon cancer	0.000911	0.000911	CcSEcCtD
Valganciclovir—Dysgeusia—Methotrexate—colon cancer	0.000907	0.000907	CcSEcCtD
Valganciclovir—Dyspnoea—Capecitabine—colon cancer	0.000906	0.000906	CcSEcCtD
Valganciclovir—Nausea—Irinotecan—colon cancer	0.000902	0.000902	CcSEcCtD
Valganciclovir—Back pain—Methotrexate—colon cancer	0.000896	0.000896	CcSEcCtD
Valganciclovir—Dyspepsia—Capecitabine—colon cancer	0.000894	0.000894	CcSEcCtD
Valganciclovir—Decreased appetite—Capecitabine—colon cancer	0.000883	0.000883	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Capecitabine—colon cancer	0.000877	0.000877	CcSEcCtD
Valganciclovir—Fatigue—Capecitabine—colon cancer	0.000876	0.000876	CcSEcCtD
Valganciclovir—Vision blurred—Methotrexate—colon cancer	0.000873	0.000873	CcSEcCtD
Valganciclovir—Pain—Capecitabine—colon cancer	0.000869	0.000869	CcSEcCtD
Valganciclovir—Constipation—Capecitabine—colon cancer	0.000869	0.000869	CcSEcCtD
Valganciclovir—Nausea—Fluorouracil—colon cancer	0.000864	0.000864	CcSEcCtD
Valganciclovir—Ill-defined disorder—Methotrexate—colon cancer	0.00086	0.00086	CcSEcCtD
Valganciclovir—Anaemia—Methotrexate—colon cancer	0.000856	0.000856	CcSEcCtD
Valganciclovir—Feeling abnormal—Capecitabine—colon cancer	0.000837	0.000837	CcSEcCtD
Valganciclovir—Malaise—Methotrexate—colon cancer	0.000836	0.000836	CcSEcCtD
Valganciclovir—Vertigo—Methotrexate—colon cancer	0.000833	0.000833	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Capecitabine—colon cancer	0.000831	0.000831	CcSEcCtD
Valganciclovir—Leukopenia—Methotrexate—colon cancer	0.000829	0.000829	CcSEcCtD
Valganciclovir—Cough—Methotrexate—colon cancer	0.000809	0.000809	CcSEcCtD
Valganciclovir—Urticaria—Capecitabine—colon cancer	0.000807	0.000807	CcSEcCtD
Valganciclovir—Abdominal pain—Capecitabine—colon cancer	0.000803	0.000803	CcSEcCtD
Valganciclovir—Body temperature increased—Capecitabine—colon cancer	0.000803	0.000803	CcSEcCtD
Valganciclovir—Convulsion—Methotrexate—colon cancer	0.000803	0.000803	CcSEcCtD
Valganciclovir—Arthralgia—Methotrexate—colon cancer	0.000789	0.000789	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000783	0.000783	CcSEcCtD
Valganciclovir—Discomfort—Methotrexate—colon cancer	0.000779	0.000779	CcSEcCtD
Valganciclovir—Confusional state—Methotrexate—colon cancer	0.000763	0.000763	CcSEcCtD
Valganciclovir—Anaphylactic shock—Methotrexate—colon cancer	0.000756	0.000756	CcSEcCtD
Valganciclovir—Infection—Methotrexate—colon cancer	0.000751	0.000751	CcSEcCtD
Valganciclovir—Hypersensitivity—Capecitabine—colon cancer	0.000748	0.000748	CcSEcCtD
Valganciclovir—Nervous system disorder—Methotrexate—colon cancer	0.000742	0.000742	CcSEcCtD
Valganciclovir—Thrombocytopenia—Methotrexate—colon cancer	0.00074	0.00074	CcSEcCtD
Valganciclovir—Skin disorder—Methotrexate—colon cancer	0.000735	0.000735	CcSEcCtD
Valganciclovir—Hyperhidrosis—Methotrexate—colon cancer	0.000731	0.000731	CcSEcCtD
Valganciclovir—Asthenia—Capecitabine—colon cancer	0.000729	0.000729	CcSEcCtD
Valganciclovir—Anorexia—Methotrexate—colon cancer	0.000721	0.000721	CcSEcCtD
Valganciclovir—Pruritus—Capecitabine—colon cancer	0.000719	0.000719	CcSEcCtD
Valganciclovir—Hypotension—Methotrexate—colon cancer	0.000707	0.000707	CcSEcCtD
Valganciclovir—Diarrhoea—Capecitabine—colon cancer	0.000695	0.000695	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000689	0.000689	CcSEcCtD
Valganciclovir—Insomnia—Methotrexate—colon cancer	0.000684	0.000684	CcSEcCtD
Valganciclovir—Paraesthesia—Methotrexate—colon cancer	0.000679	0.000679	CcSEcCtD
Valganciclovir—Dyspnoea—Methotrexate—colon cancer	0.000674	0.000674	CcSEcCtD
Valganciclovir—Somnolence—Methotrexate—colon cancer	0.000672	0.000672	CcSEcCtD
Valganciclovir—Dizziness—Capecitabine—colon cancer	0.000672	0.000672	CcSEcCtD
Valganciclovir—Dyspepsia—Methotrexate—colon cancer	0.000666	0.000666	CcSEcCtD
Valganciclovir—Decreased appetite—Methotrexate—colon cancer	0.000657	0.000657	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Methotrexate—colon cancer	0.000653	0.000653	CcSEcCtD
Valganciclovir—Fatigue—Methotrexate—colon cancer	0.000652	0.000652	CcSEcCtD
Valganciclovir—Pain—Methotrexate—colon cancer	0.000647	0.000647	CcSEcCtD
Valganciclovir—Vomiting—Capecitabine—colon cancer	0.000646	0.000646	CcSEcCtD
Valganciclovir—Dermatitis—Capecitabine—colon cancer	0.00064	0.00064	CcSEcCtD
Valganciclovir—Headache—Capecitabine—colon cancer	0.000636	0.000636	CcSEcCtD
Valganciclovir—Feeling abnormal—Methotrexate—colon cancer	0.000623	0.000623	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Methotrexate—colon cancer	0.000618	0.000618	CcSEcCtD
Valganciclovir—Nausea—Capecitabine—colon cancer	0.000603	0.000603	CcSEcCtD
Valganciclovir—Urticaria—Methotrexate—colon cancer	0.000601	0.000601	CcSEcCtD
Valganciclovir—Abdominal pain—Methotrexate—colon cancer	0.000598	0.000598	CcSEcCtD
Valganciclovir—Body temperature increased—Methotrexate—colon cancer	0.000598	0.000598	CcSEcCtD
Valganciclovir—Hypersensitivity—Methotrexate—colon cancer	0.000557	0.000557	CcSEcCtD
Valganciclovir—Asthenia—Methotrexate—colon cancer	0.000543	0.000543	CcSEcCtD
Valganciclovir—Pruritus—Methotrexate—colon cancer	0.000535	0.000535	CcSEcCtD
Valganciclovir—Diarrhoea—Methotrexate—colon cancer	0.000517	0.000517	CcSEcCtD
Valganciclovir—Dizziness—Methotrexate—colon cancer	0.0005	0.0005	CcSEcCtD
Valganciclovir—Vomiting—Methotrexate—colon cancer	0.000481	0.000481	CcSEcCtD
Valganciclovir—Dermatitis—Methotrexate—colon cancer	0.000476	0.000476	CcSEcCtD
Valganciclovir—Headache—Methotrexate—colon cancer	0.000474	0.000474	CcSEcCtD
Valganciclovir—Nausea—Methotrexate—colon cancer	0.000449	0.000449	CcSEcCtD
